Hrt Financial LP Inovio Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.35 - $0.53 $42,462 - $64,299	121,320 Added 628.18%	140,633 $71,000
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $101,007 - $154,169	-265,809 Reduced 93.23%	19,313 $7,000
Q2 2023 Aug 11, 2023	BUY	$0.39 - $0.94 $111,197 - $268,014	285,122 New	285,122 $127,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $89,991 - $157,560	-30,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $116,067 - $173,519	-23,260 Reduced 43.43%	30,300 $151,000
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $155,601 - $210,583	-21,732 Reduced 28.86%	53,560 $383,000
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $469,069 - $755,178	75,292 New	75,292 $697,000
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $319,569 - $1.51 Million	-107,238 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $211,258 - $398,925	107,238 New	107,238 $353,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $544M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.